Dihydrouracil Dehydrogenase (NAD+)
"Dihydrouracil Dehydrogenase (NAD+)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.
Descriptor ID |
D050744
|
MeSH Number(s) |
D08.811.682.660.325
|
Concept/Terms |
Dihydrouracil Dehydrogenase (NAD+)- Dihydrouracil Dehydrogenase (NAD+)
- Dihydrouracil Dehydrogenase
- Dehydrogenase, Dihydrouracil
- Dihydrouracil Dehydrogenase (NAD)
- Dihydrothymine Dehydrogenase (NAD)
|
Below are MeSH descriptors whose meaning is more general than "Dihydrouracil Dehydrogenase (NAD+)".
Below are MeSH descriptors whose meaning is more specific than "Dihydrouracil Dehydrogenase (NAD+)".
This graph shows the total number of publications written about "Dihydrouracil Dehydrogenase (NAD+)" by people in this website by year, and whether "Dihydrouracil Dehydrogenase (NAD+)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihydrouracil Dehydrogenase (NAD+)" by people in Profiles.
-
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr 01; 91(7):1256-63.